NVAX · Healthcare · $1.8B
Pre-market $10.83+0.19%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“Novavax의 핵심 무기는 'Matrix-M'이라는 면역 증강 물질(adjuvant)이에요.”
In the company's words · 2026 1분기 earnings call